The US regulator has cleared weight-loss drug Wegovy (semaglutide) for patients with MASH and moderate to advanced liver scarring (fibrosis), without cirrhosis, in combination with a reduced-calorie diet and exercise
If not, what are the impediments
The decision belongs with a licensed prescriber who weighs your goals, health, tolerability, and budget
En la siguiente tabla precisamos mayores detalles sobre las diferencias entre Mounjaro y Ozempic: Su eficacia en la reduccin de la glucosa en sangre y la prdida de peso ha demostrado ser superior gracias a su mecanismo dual que activa tanto los receptores GLP-1 como los GIP
Physiology of folate and vitamin B12 in health and disease
This article briefly summarizes the evidence, benefits, limitations, and potential best candidates for GLP-1 agonist treatment for alcohol use problems, considering both harm reduction (moderate, safer drinking) and abstinence goals